{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:52:05Z","timestamp":1785711125789,"version":"3.56.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["359706"],"award-info":[{"award-number":["359706"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["356056"],"award-info":[{"award-number":["356056"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["356992"],"award-info":[{"award-number":["356992"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030846","name":"Biokeskus Kuopio, It\u00e4-Suomen yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Cancer Foundation Finland","doi-asserted-by":"publisher","award":["230130"],"award-info":[{"award-number":["230130"]}],"id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.nano.2026.102931","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:29:10Z","timestamp":1773854950000},"page":"102931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Biomimetic porous silicon for rationally designed combination therapy to induce immunogenic cell death"],"prefix":"10.1016","volume":"74","author":[{"given":"Silja","family":"Saarela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Happonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milla-Iida","family":"Laari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna","family":"Sivonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Zakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh","family":"Saba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Tampio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Klefstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Pajula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina M.","family":"Huttunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa-Pekka","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wujun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2026.102931_bb0005","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.clon.2011.03.013","article-title":"Metastatic triple-negative breast cancer","volume":"23","author":"Rakha","year":"2011","journal-title":"Clin Oncol"},{"key":"10.1016\/j.nano.2026.102931_bb0010","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nano.2026.102931_bb0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.radonc.2011.07.007","article-title":"Adjuvant chemotherapy and radiotherapy in triple-negative breast carcinoma: a prospective randomized controlled multi-center trial","volume":"100","author":"Wang","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.nano.2026.102931_bb0020","article-title":"Immunogenic cell death activates the tumor immune microenvironment to boost the immunotherapy efficiency","volume":"9","author":"Li","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.nano.2026.102931_bb0025","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1158\/2326-6066.CIR-17-0229","article-title":"Natural killer T-cell immunotherapy in combination with chemotherapy-induced immunogenic cell death targets metastatic breast cancer","volume":"5","author":"Gebremeskel","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.nano.2026.102931_bb0030","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1021\/acsapm.0c00938","article-title":"Induction of immunogenic cell death in breast cancer by conductive polymer nanoparticle-mediated Photothermal therapy","volume":"2","author":"Huff","year":"2020","journal-title":"ACS Appl Polym Mater"},{"key":"10.1016\/j.nano.2026.102931_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-03221-2","article-title":"Detection of immunogenic cell death and its relevance for cancer therapy","volume":"11","author":"Fucikova","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.nano.2026.102931_bb0040","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.7150\/thno.45391","article-title":"Nanomicelle protects the immune activation effects of paclitaxel and sensitizes tumors to anti-PD-1 immunotherapy","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.nano.2026.102931_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119787","article-title":"Induction of immunogenic cell death of cancer cells through nanoparticle-mediated dual chemotherapy and photothermal therapy","volume":"589","author":"Heshmati Aghda","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2026.102931_bb0050","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrc.2017.93","article-title":"Transport of drugs from blood vessels to tumour tissue","volume":"17","author":"Dewhirst","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nano.2026.102931_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051389","article-title":"Combination of chemotherapy and mild hyperthermia using targeted nanoparticles: a potential treatment modality for breast cancer","volume":"15","author":"Kaur","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.102931_bb0060","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s40199-023-00463-1","article-title":"Simulation of drug-drug interactions between breast cancer chemotherapeutic agents and antiemetic drugs","volume":"31","author":"Deb","year":"2023","journal-title":"DARU J Pharm Sci"},{"key":"10.1016\/j.nano.2026.102931_bb0065","doi-asserted-by":"crossref","first-page":"23529","DOI":"10.1021\/acsami.8b04557","article-title":"Scalable synthesis of biodegradable black mesoporous silicon nanoparticles for highly efficient photothermal therapy","volume":"10","author":"Xu","year":"2018","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2026.102931_bb0070","doi-asserted-by":"crossref","first-page":"13549","DOI":"10.1073\/pnas.2232479100","article-title":"Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance","volume":"100","author":"Hirsch","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nano.2026.102931_bb0075","article-title":"Inorganic nanomaterials for photothermal-based cancer theranostics","volume":"4","author":"Wen","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.nano.2026.102931_bb0080","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.actbio.2022.08.073","article-title":"Black porous silicon as a photothermal agent and immunoadjuvant for efficient antitumor immunotherapy","volume":"152","author":"Xu","year":"2022","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2026.102931_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119657","article-title":"Thermal dose as a universal tool to evaluate nanoparticle-induced photothermal therapy","volume":"587","author":"Happonen","year":"2020","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2026.102931_bb0090","first-page":"1","article-title":"Multi-stage mechanisms of tumor metastasis and therapeutic strategies","volume":"9","author":"Liu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.nano.2026.102931_bb0095","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41467-018-03473-9","article-title":"Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer","volume":"9","author":"Nam","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.102931_bb0100","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.1038\/s41598-018-26978-1","article-title":"Temperature-dependent cell death patterns induced by functionalized gold nanoparticle photothermal therapy in melanoma cells","volume":"8","author":"Zhang","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2026.102931_bb0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1021\/mp300494p","article-title":"Development of porous silicon nanocarriers for parenteral peptide delivery","volume":"10","author":"Kovalainen","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2026.102931_bb0110","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jconrel.2005.08.017","article-title":"Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs","volume":"108","author":"Salonen","year":"2005","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2026.102931_bb0115","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2217\/nnm.11.19","article-title":"Nanoparticle PEGylation for imaging and therapy","volume":"6","author":"Jokerst","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2026.102931_bb0120","doi-asserted-by":"crossref","first-page":"40392","DOI":"10.1021\/acsami.1c11875","article-title":"Comparison between fluorescence imaging and elemental analysis to determine biodistribution of inorganic nanoparticles with strong light absorption","volume":"13","author":"Tamarov","year":"2021","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2026.102931_bb0125","article-title":"Systematic design of cell membrane coating to improve tumor targeting of nanoparticles","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.102931_bb0130","article-title":"Cell membrane coating integrity affects the internalization mechanism of biomimetic nanoparticles","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.102931_bb0135","series-title":"Microtubule Inhibition Triggers MYC-mediated Immunogenic Cell Death in Breast Cancer","author":"Liu","year":"2025"},{"key":"10.1016\/j.nano.2026.102931_bb0140","doi-asserted-by":"crossref","first-page":"46521","DOI":"10.1021\/acsami.5c05042","article-title":"Drug-free approach to regulate undruggable proto-oncogene MYC using biomimetic porous nanoparticles for cancer immunotherapy","volume":"17","author":"Happonen","year":"2025","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2026.102931_bb0145","doi-asserted-by":"crossref","first-page":"6734","DOI":"10.1021\/cm503004b","article-title":"A nanostopper approach to selectively engineer the surfaces of mesoporous silicon","volume":"26","author":"Xu","year":"2014","journal-title":"Chem Mater"},{"key":"10.1016\/j.nano.2026.102931_bb0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.actbio.2014.11.019","article-title":"Improved stability and biocompatibility of nanostructured silicon drug carrier for intravenous administration","volume":"13","author":"Nakki","year":"2015","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2026.102931_bb0155","series-title":"naitsok\/controlled-ptt: Controlled PTT 2.0.4 2023","author":"Tamarov","year":"2023"},{"key":"10.1016\/j.nano.2026.102931_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123764","article-title":"A PEG-assisted membrane coating to prepare biomimetic mesoporous silicon for PET\/CT imaging of triple-negative breast cancer","volume":"652","author":"Wen","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2026.102931_bb0165","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.2147\/IJN.S103556","article-title":"Vitamin E succinate-conjugated F68 micelles for mitoxantrone delivery in enhancing anticancer activity","volume":"11","author":"Liu","year":"2016","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2026.102931_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15102507","article-title":"Biomimetic inorganic nanovectors as tumor-targeting theranostic platform against triple-negative breast cancer","volume":"15","author":"Wen","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2026.102931_bb0175","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.3390\/cimb44050135","article-title":"Cold atmospheric plasma-activated media improve paclitaxel efficacy on breast cancer cells in a combined treatment model","volume":"44","author":"Mihai","year":"2022","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.nano.2026.102931_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11060559","article-title":"Enhanced anticancer activity of nanoformulation of Dasatinib against triple-negative breast cancer","volume":"11","author":"Bahman","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.nano.2026.102931_bb0185","article-title":"Combination of photothermal, prodrug and tumor cell camouflage technologies for triple-negative breast cancer treatment","volume":"13","author":"Zhang","year":"2022","journal-title":"Mater Today Adv"},{"key":"10.1016\/j.nano.2026.102931_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103698","article-title":"Biomimetic cancer cell-coated albumin nanoparticles for enhanced colloidal stability and homotypic targeting of breast cancer cells","volume":"75","author":"Cao","year":"2022","journal-title":"J Drug Delivery Sci Technol"},{"key":"10.1016\/j.nano.2026.102931_bb0195","doi-asserted-by":"crossref","first-page":"10608","DOI":"10.1039\/D4RA01026D","article-title":"Cancer cell membrane-coated nanoparticles: a promising anti-tumor bionic platform","volume":"14","author":"Guo","year":"2024","journal-title":"RSC Adv"},{"key":"10.1016\/j.nano.2026.102931_bb0200","article-title":"HMGB1 promotes resistance to doxorubicin in human hepatocellular carcinoma cells by inducing autophagy via the AMPK\/mTOR signaling pathway","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.nano.2026.102931_bb0205","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuropharm.2018.08.040","article-title":"Paclitaxel-induced HMGB1 release from macrophages and its implication for peripheral neuropathy in mice: evidence for a neuroimmune crosstalk","volume":"141","author":"Sekiguchi","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nano.2026.102931_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105921","article-title":"BET bromodomain inhibitor JQ1 promotes immunogenic cell death in tongue squamous cell carcinoma","volume":"76","author":"Wang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.nano.2026.102931_bb0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.semcdb.2023.10.007","article-title":"Immunogenic cell stress and death in the treatment of cancer","volume":"156","author":"Pan","year":"2024","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.nano.2026.102931_bb0220","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.nano.2026.102931_bb0225","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-019-11269-8","article-title":"Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death","volume":"10","author":"Li","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2026.102931_bb0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1021\/acsnano.5b00021","article-title":"Elucidating the fundamental mechanisms of cell death triggered by photothermal therapy","volume":"9","author":"Melamed","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2026.102931_bb0235","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/MCB.01365-08","article-title":"Brd4 coactivates transcriptional activation of NF-\u03baB via specific binding to acetylated RelA","volume":"29","author":"Huang","year":"2008","journal-title":"Mol Cell Biol"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963426000328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T22:29:49Z","timestamp":1785709789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963426000328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":47,"alternative-id":["S1549963426000328"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2026.102931","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomimetic porous silicon for rationally designed combination therapy to induce immunogenic cell death","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2026.102931","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102931"}}